|
1
|
The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.
|
J Clin Oncol
|
2004
|
5.09
|
|
2
|
National practice patterns and time trends in androgen ablation for localized prostate cancer.
|
J Natl Cancer Inst
|
2003
|
4.81
|
|
3
|
The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.
|
J Urol
|
2004
|
4.66
|
|
4
|
Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE).
|
J Urol
|
2003
|
2.93
|
|
5
|
Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
|
J Urol
|
2003
|
1.93
|
|
6
|
Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer.
|
Urology
|
2002
|
1.90
|
|
7
|
Assessment of prognosis with the total illness burden index for prostate cancer: aiding clinicians in treatment choice.
|
Cancer
|
2007
|
1.68
|
|
8
|
Psychological impact of erectile dysfunction: validation of a new health related quality of life measure for patients with erectile dysfunction.
|
J Urol
|
2002
|
1.54
|
|
9
|
Predicting quality of life after radical prostatectomy: results from CaPSURE.
|
J Urol
|
2004
|
1.52
|
|
10
|
Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE.
|
J Urol
|
2008
|
1.39
|
|
11
|
Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
|
J Urol
|
2005
|
1.37
|
|
12
|
Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?
|
J Urol
|
2002
|
1.30
|
|
13
|
Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE.
|
J Urol
|
2003
|
1.25
|
|
14
|
Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database.
|
Diabetes Care
|
2003
|
1.24
|
|
15
|
Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer.
|
J Urol
|
2003
|
1.20
|
|
16
|
Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor.
|
J Urol
|
2002
|
1.20
|
|
17
|
Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE.
|
Urology
|
2002
|
1.16
|
|
18
|
Is quality of life different for men with erectile dysfunction and prostate cancer compared to men with erectile dysfunction due to other causes? Results from the ExCEED data base.
|
J Urol
|
2003
|
1.12
|
|
19
|
Mental health in men treated for early stage prostate carcinoma: a posttreatment, longitudinal quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor.
|
Cancer
|
2002
|
1.10
|
|
20
|
Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE.
|
J Urol
|
2003
|
1.09
|
|
21
|
Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE.
|
J Urol
|
2004
|
1.09
|
|
22
|
Bowel function and bother after treatment for early stage prostate cancer: a longitudinal quality of life analysis from CaPSURE.
|
J Urol
|
2004
|
1.04
|
|
23
|
How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE.
|
Urology
|
2003
|
1.03
|
|
24
|
Aerobic exercise and its impact on musculoskeletal pain in older adults: a 14 year prospective, longitudinal study.
|
Arthritis Res Ther
|
2005
|
1.00
|
|
25
|
Patterns of care in community-based oncology practices for anemia associated with myelosuppressive chemotherapy.
|
J Oncol Pract
|
2009
|
0.98
|
|
26
|
Patterns of secondary cancer treatment for biochemical failure following radical prostatectomy: data from CaPSURE.
|
J Urol
|
2004
|
0.98
|
|
27
|
How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor.
|
J Urol
|
2002
|
0.97
|
|
28
|
Impact of patient educational level on treatment for patients with prostate cancer: data from CaPSURE.
|
Urology
|
2003
|
0.96
|
|
29
|
Predictors of treatment after initial surveillance in men with prostate cancer: results from CaPSURE.
|
J Urol
|
2003
|
0.94
|
|
30
|
Sociodemographic characteristics and health related quality of life in men attending prostate cancer support groups.
|
J Urol
|
2002
|
0.94
|
|
31
|
Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
|
J Urol
|
2002
|
0.94
|
|
32
|
Longitudinal differences in disease specific quality of life in men with erectile dysfunction: results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction study.
|
J Urol
|
2003
|
0.90
|
|
33
|
Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer.
|
Urology
|
2002
|
0.86
|
|
34
|
Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.
|
J Med Econ
|
2015
|
0.84
|
|
35
|
Demographics, insurance coverage, and utilization of medical services in newly diagnosed prostate cancer: data from caPSURE.
|
Manag Care Interface
|
2005
|
0.82
|
|
36
|
Realizing the benefits of practical clinical trials.
|
JAMA
|
2004
|
0.82
|
|
37
|
Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: data from CaPSURE.
|
Int J Radiat Oncol Biol Phys
|
2004
|
0.78
|
|
38
|
Revalidation of the original Cedars-Sinai health-related quality of life in rheumatoid arthritis questionnaire.
|
J Rheumatol
|
2006
|
0.76
|
|
39
|
Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
|
BJU Int
|
2008
|
0.76
|
|
40
|
Development of a new instrument for rheumatoid arthritis: the Cedars-Sinai Health-Related Quality of Life instrument (CSHQ-RA).
|
Arthritis Rheum
|
2003
|
0.76
|
|
41
|
Development and validation of Cedars-Sinai Health-Related Quality of Life in Rheumatoid Arthritis (CSHQ-RA) short form instrument.
|
Arthritis Rheum
|
2004
|
0.76
|